V. Berlinskienės vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,293,322 | 2,905,253 | 1,720,717 | - | 984,401 | 5,008,236 | 8,656,255 | 14,783,680 |
| Profit before tax | 61,072 | 20,233 | -23,614 | -20,901 | 19,956 | 22,977 | 53,533 | 107,020 |
| Net profit | 54,911 | 17,196 | -23,614 | -20,901 | 18,374 | 18,237 | 45,097 | 88,812 |
| Equity | 74,146 | 41,343 | 17,729 | -3,173 | 15,201 | 33,438 | 78,536 | 167,348 |
| Liabilities | 646,528 | 710,168 | 147,257 | 143,726 | 969,950 | 1,564,580 | 2,187,748 | 2,582,066 |
| Non-current assets | 127,208 | 121,644 | 121,642 | 121,642 | 130,390 | 229,902 | 212,238 | 193,231 |
| Current assets | 593,466 | 629,867 | 43,344 | 18,911 | 854,761 | 1,368,116 | 2,053,855 | 2,552,920 |
| Total assets | 720,674 | 751,511 | 164,986 | 140,553 | 985,151 | 1,598,018 | 2,266,093 | 2,746,151 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 25,528 | - | 47,003 |
| Social insurance contributions | - | - | - | - | - | 27,511 | 40,943 | 48,174 |
|
Financial indicators
|
||||||||
| Revenue change y/y | 0.0% | +26.7% | -40.8% | - | - | +408.8% | +72.8% | +70.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.6% | 2.3% | -14.3% | -14.9% | 1.9% | 1.1% | 2.0% | 3.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 74.1% | 41.6% | -133.2% | - | 120.9% | 54.5% | 57.4% | 53.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.4% | 0.6% | -1.4% | - | 1.9% | 0.4% | 0.5% | 0.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.7% | 0.7% | -1.4% | - | 2.0% | 0.5% | 0.6% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 8.7 | 17.2 | 8.3 | - | 63.8 | 46.8 | 27.9 | 15.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 286,665 | 363,157 | 286,786 | - | 251,334 | 760,749 | 1,167,130 | 1,847,960 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
V. Berlinskienės vaistinė - Social security debts
The company had no debts to Sodra
V. Berlinskienės vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
V. Berlinskienes vaistine, UAB, a Private Limited Liability Company (code 164245814), operates in the retail sale of pharmaceutical products. In 2025, the latest year, the company generated revenue of €14.78M and net profit of €88.8K, with a profit margin of 0.6%. Revenue increased by 70.8% year on year and by 195.2% over two years, showing a strong upward trajectory from €5.01M in 2023 to €8.66M in 2024 and €14.78M in 2025. Net profit also rose steadily from €18.2K in 2023 to €45.1K in 2024 and €88.8K in 2025. The balance sheet remained relatively small compared with turnover: total assets were €2.75M, equity €167.3K and liabilities €2.58M at the end of 2025. Asset turnover was high at 5.38x, while revenue per employee reached €1.85M and profit per employee €11.1K. Overall, the company expanded quickly in 2025, but profitability remained modest and the equity base was thin relative to liabilities.